AlzChem Financial Statements From 2010 to 2024
| ACT Stock | EUR 59.60 2.20 3.83% |
Check AlzChem Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AlzChem Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . AlzChem financial statements analysis is a perfect complement when working with AlzChem Group Valuation or Volatility modules.
AlzChem |
AlzChem Group AG Company EBITDA Analysis
AlzChem Group's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current AlzChem Group EBITDA | 62.69 M |
Most of AlzChem Group's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AlzChem Group AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, AlzChem Group AG reported earnings before interest,tax, depreciation and amortization of 62.69 M. This is much higher than that of the sector and significantly higher than that of the EBITDA industry. The ebitda for all Germany stocks is notably lower than that of the firm.
AlzChem Group AG Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AlzChem Group's current stock value. Our valuation model uses many indicators to compare AlzChem Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AlzChem Group competition to find correlations between indicators driving AlzChem Group's intrinsic value. More Info.AlzChem Group AG is rated fourth in current valuation category among its peers. It is rated third in price to book category among its peers . The ratio of Current Valuation to Price To Book for AlzChem Group AG is about 200,200,603 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AlzChem Group's earnings, one of the primary drivers of an investment's value.About AlzChem Group Financial Statements
AlzChem Group stakeholders use historical fundamental indicators, such as AlzChem Group's revenue or net income, to determine how well the company is positioned to perform in the future. Although AlzChem Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in AlzChem Group's assets and liabilities are reflected in the revenues and expenses on AlzChem Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AlzChem Group AG. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in AlzChem Stock
AlzChem Group financial ratios help investors to determine whether AlzChem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AlzChem with respect to the benefits of owning AlzChem Group security.